De-Kui Zhang (Dekui Zhang)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Helicobacter Pylori

Prognostic Factors

Stem Cell Transplantation

Randomized Controlled Trial

Top Venues

Expert review of gastroenterology & hepatology

Pharmaceutical biology

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Hu, Hao Mei, Na-Yun Su, Wen-Jing Sun, De-Kui Zhang, Li-Lin Fan, Ping He, Jie Pan, Xing-Wei Wang, Pei-Ying Zou, Yu-Xiang Liu, Yan Guo, Chun-Hui Lan
Eradication rates of Helicobacter pylori in treatment-naive patients following 14-day vonoprazan-amoxicillin dual therapy: A multicenter randomized controlled trial in China. Helicobacter (2023)
Yong Xie, Yi Hu, Yin Zhu, Hong Wang, Qi-Zhi Wang, Yan-Qing Li, Jiang-Bin Wang, Zhen-Yu Zhang, De-Kui Zhang, Xiao-Wei Liu, Nong Hua Lu
Colloidal bismuth pectin-containing quadruple therapy as the first-line treatment of Helicobacter pylori infection: A multicenter, randomized, double-blind, non-inferiority clinical trial. Helicobacter (2023)
Bin Xiong, Fei-Xue Song, Hui-Ling Chen, Xiao-Juan Wang, Zheng-Xu Jin, Ti-Yun Han, Yi Li, De-Kui Zhang
Discoidin domain receptor 1a (DDR1a) confers 5-fluorouracil cytotoxicity in LoVo cell via PI3K/AKT/Bcl-2 pathway. Bioengineered 13 (4) (2022)
Long Cheng, Xiaoying Wang, Xueni Ma, Huimei Xu, Yifan Yang, De-Kui Zhang
Effect of dihydromyricetin on hepatic encephalopathy associated with acute hepatic failure in mice. Pharmaceutical biology 59 (1) (2021)
Jian-Wei Yun, Zhiping Wu, Guoqing Qi, Tiyun Han, De-Kui Zhang
The high-dose amoxicillin-proton pump inhibitor dual therapy in eradication of Helicobacter pylori infection. Expert review of gastroenterology & hepatology 15 (2) (2020)